The Jonsson Comprehensive Cancer Center was formed in 1974 upon the recommendation of scientists at the David Geffen School of Medicine at UCLA for a devoted facility and through the philanthropy of the Jonsson Cancer Center Foundation. The partnership with the Jonsson Cancer Center Foundation has provided funds for cancer research and cancer-related programs.
The Jonsson Comprehensive Cancer Center at UCLA is designated as a Comprehensive Cancer Center by the National Cancer Institute due to its focus on patient care, basic and clinical research, prevention, education, outreach and training. As one of the nation's leading cancer research and treatment centers, UCLA receives an estimated $40.1 million dollars each year to conduct oncological research from the National Cancer Institute.
The Jonsson Comprehensive Cancer Center’s commitment to cutting edge research and patient-centered therapies continues to support its ranking and accolades in the US News and World Report as one of “America’s Top 10 Cancer Hospitals” and as “America’s Best Hospital in the West.”
The Jonsson Comprehensive Cancer Center is situated to provide the latest research developments to provide improved cancer treatment options. The integrated research environment provides collaboration of laboratory scientists and physicians within clinical, translational, and prevention research studies.
With regard to lung cancers, Jonsson Comprehensive Cancer Center was awarded a SPORE grant (Specialized Programs of Research Excellence) through the National Cancer Institute to provide an integrated research structure that allows cancer centers to bring together top scientists from multidisciplinary fields to address specific lung cancer questions and to bring cutting edge research directly from the laboratory to the bedside.
Radiation oncology, surgical oncology, clinical trials, chemotherapy, palliative care, state of the art diagnostics and imaging services, pathology, genetic counseling, hormone therapy, biological therapy, complementary and alternative medicine, nutrition and physical therapy, and comprehensive and preventive care are all options in the Jonsson Comprehensive Cancer Center cancer treatment program.
Robert Cameron, MD, is a thoracic oncologist that specializes in cardiothoracic surgery with clinical interests in treating mesothelioma. He integrates multimodal therapies with the most advanced surgical techniques including VATS, robotics (Da Vinci), lasers (Nd-YAG, Homium), and stents. He is the Director of the Comprehensive Mesothelioma Program at UCLA.
This facility has been designated as an NCI center.